#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=Mary C. Tanner
1-1	0-4	Mary	person[1]	new[1]	coref	2-1[2_1]
1-2	5-7	C.	person[1]	new[1]	_	_
1-3	8-14	Tanner	person[1]	new[1]	_	_

#Text=Mary Catherine Tanner is an investment banker , with more than 25 years of experience on Wall Street .
2-1	15-19	Mary	person[2]	giv[2]	coref	2-5[4_2]
2-2	20-29	Catherine	person[2]	giv[2]	_	_
2-3	30-36	Tanner	person[2]	giv[2]	_	_
2-4	37-39	is	_	_	_	_
2-5	40-42	an	person[4]	giv[4]	ana	3-1[0_4]
2-6	43-53	investment	abstract|person[4]	new|giv[4]	_	_
2-7	54-60	banker	person[4]	giv[4]	_	_
2-8	61-62	,	person[4]	giv[4]	_	_
2-9	63-67	with	person[4]	giv[4]	_	_
2-10	68-72	more	person[4]|time[5]	giv[4]|new[5]	_	_
2-11	73-77	than	person[4]|time[5]	giv[4]|new[5]	_	_
2-12	78-80	25	person[4]|time[5]	giv[4]|new[5]	_	_
2-13	81-86	years	person[4]|time[5]	giv[4]|new[5]	_	_
2-14	87-89	of	person[4]|time[5]	giv[4]|new[5]	_	_
2-15	90-100	experience	person[4]|time[5]|abstract[6]	giv[4]|new[5]|new[6]	_	_
2-16	101-103	on	person[4]|time[5]|abstract[6]	giv[4]|new[5]|new[6]	_	_
2-17	104-108	Wall	person[4]|time[5]|abstract[6]|place[7]	giv[4]|new[5]|new[6]|new[7]	_	_
2-18	109-115	Street	person[4]|time[5]|abstract[6]|place[7]	giv[4]|new[5]|new[6]|new[7]	_	_
2-19	116-117	.	_	_	_	_

#Text=She specializes in the areas of biotechnology , pharmaceuticals , and health care services . [ 4 ] [ 5 ]
3-1	118-121	She	person	giv	ana	4-1
3-2	122-133	specializes	_	_	_	_
3-3	134-136	in	_	_	_	_
3-4	137-140	the	abstract[9]	new[9]	_	_
3-5	141-146	areas	abstract[9]	new[9]	_	_
3-6	147-149	of	abstract[9]	new[9]	_	_
3-7	150-163	biotechnology	abstract[9]|abstract	new[9]|new	_	_
3-8	164-165	,	abstract[9]	new[9]	_	_
3-9	166-181	pharmaceuticals	abstract[9]|substance	new[9]|new	coref	4-4[18_0]
3-10	182-183	,	abstract[9]	new[9]	_	_
3-11	184-187	and	abstract[9]	new[9]	_	_
3-12	188-194	health	abstract[9]|abstract[12]|abstract[13]	new[9]|new[12]|new[13]	_	_
3-13	195-199	care	abstract[9]|abstract[12]|abstract[13]	new[9]|new[12]|new[13]	_	_
3-14	200-208	services	abstract[9]|abstract[13]	new[9]|new[13]	_	_
3-15	209-210	.	_	_	_	_
3-16	211-212	[	_	_	_	_
3-17	213-214	4	abstract	new	coref	5-26
3-18	215-216	]	_	_	_	_
3-19	217-218	[	_	_	_	_
3-20	219-220	5	abstract	new	coref	5-29
3-21	221-222	]	_	_	_	_

#Text=Her expertise includes ethical pharmaceuticals and green technology . [ 1 ]
4-1	223-226	Her	person|abstract[17]	giv|new[17]	ana	5-8
4-2	227-236	expertise	abstract[17]	new[17]	_	_
4-3	237-245	includes	_	_	_	_
4-4	246-253	ethical	substance[18]|substance[19]	giv[18]|giv[19]	coref|coref	4-4[19_18]|23-28[0_19]
4-5	254-269	pharmaceuticals	substance[18]|substance[19]	giv[18]|giv[19]	_	_
4-6	270-273	and	substance[19]	giv[19]	_	_
4-7	274-279	green	substance[19]|abstract[20]	giv[19]|new[20]	_	_
4-8	280-290	technology	substance[19]|abstract[20]	giv[19]|new[20]	_	_
4-9	291-292	.	_	_	_	_
4-10	293-294	[	_	_	_	_
4-11	295-296	1	abstract	new	coref	14-25
4-12	297-298	]	_	_	_	_

#Text=Fluent in both English and French , she specializes in cross-border transactions between large and small companies , corporate partnering and minority investments . [ 4 ] [ 5 ]
5-1	299-305	Fluent	_	_	_	_
5-2	306-308	in	_	_	_	_
5-3	309-313	both	abstract[22]	new[22]	_	_
5-4	314-321	English	abstract[22]	new[22]	_	_
5-5	322-325	and	_	_	_	_
5-6	326-332	French	abstract	new	_	_
5-7	333-334	,	_	_	_	_
5-8	335-338	she	person	giv	coref	6-5
5-9	339-350	specializes	_	_	_	_
5-10	351-353	in	_	_	_	_
5-11	354-366	cross-border	event[25]	new[25]	_	_
5-12	367-379	transactions	event[25]	new[25]	_	_
5-13	380-387	between	event[25]	new[25]	_	_
5-14	388-393	large	event[25]|organization[26]	new[25]|new[26]	_	_
5-15	394-397	and	event[25]|organization[26]	new[25]|new[26]	_	_
5-16	398-403	small	event[25]|organization[26]	new[25]|new[26]	_	_
5-17	404-413	companies	event[25]|organization[26]	new[25]|new[26]	_	_
5-18	414-415	,	event[25]	new[25]	_	_
5-19	416-425	corporate	event[25]|abstract[27]	new[25]|new[27]	_	_
5-20	426-436	partnering	event[25]|abstract[27]	new[25]|new[27]	_	_
5-21	437-440	and	event[25]	new[25]	_	_
5-22	441-449	minority	event[25]|abstract[28]	new[25]|new[28]	_	_
5-23	450-461	investments	event[25]|abstract[28]	new[25]|new[28]	_	_
5-24	462-463	.	_	_	_	_
5-25	464-465	[	_	_	_	_
5-26	466-467	4	abstract	giv	coref	7-23
5-27	468-469	]	_	_	_	_
5-28	470-471	[	_	_	_	_
5-29	472-473	5	abstract	giv	coref	7-26
5-30	474-475	]	_	_	_	_

#Text=As of 2014 , Tanner was Senior Managing Director of EVOLUTION Life Science Partners ( ELSP ) , and a co-founder and chair of Life Science Partners LLP .
6-1	476-478	As	_	_	_	_
6-2	479-481	of	_	_	_	_
6-3	482-486	2014	time	new	coref	27-3
6-4	487-488	,	_	_	_	_
6-5	489-495	Tanner	person	giv	coref	6-7[33_0]
6-6	496-499	was	_	_	_	_
6-7	500-506	Senior	person[33]|person[34]	giv[33]|giv[34]	coref|coref	6-7[34_33]|8-1[0_34]
6-8	507-515	Managing	person[33]|person[34]	giv[33]|giv[34]	_	_
6-9	516-524	Director	person[33]|person[34]	giv[33]|giv[34]	_	_
6-10	525-527	of	person[33]|person[34]	giv[33]|giv[34]	_	_
6-11	528-537	EVOLUTION	person[33]|person[34]|organization|organization[38]	giv[33]|giv[34]|new|new[38]	coref|coref	22-30[141_38]|27-9
6-12	538-542	Life	person[33]|person[34]|person|organization[37]|organization[38]	giv[33]|giv[34]|new|new[37]|new[38]	coref|coref	6-25|6-25[43_37]
6-13	543-550	Science	person[33]|person[34]|organization[37]|organization[38]	giv[33]|giv[34]|new[37]|new[38]	_	_
6-14	551-559	Partners	person[33]|person[34]|organization[38]	giv[33]|giv[34]|new[38]	_	_
6-15	560-561	(	person[34]	giv[34]	_	_
6-16	562-566	ELSP	person[34]|abstract	giv[34]|new	coref	27-14
6-17	567-568	)	person[34]	giv[34]	_	_
6-18	569-570	,	person[34]	giv[34]	_	_
6-19	571-574	and	person[34]	giv[34]	_	_
6-20	575-576	a	person[34]|person[40]	giv[34]|new[40]	ana	7-2[0_40]
6-21	577-587	co-founder	person[34]|person[40]	giv[34]|new[40]	_	_
6-22	588-591	and	person[34]	giv[34]	_	_
6-23	592-597	chair	person[34]|person[41]	giv[34]|new[41]	_	_
6-24	598-600	of	person[34]|person[41]	giv[34]|new[41]	_	_
6-25	601-605	Life	person[34]|person[41]|person|organization[43]|place[44]|organization[45]	giv[34]|new[41]|giv|giv[43]|new[44]|new[45]	coref|coref|coref|coref	22-30|27-9[182_43]|28-21[198_44]|28-21[199_45]
6-26	606-613	Science	person[34]|person[41]|organization[43]|place[44]|organization[45]	giv[34]|new[41]|giv[43]|new[44]|new[45]	_	_
6-27	614-622	Partners	person[34]|person[41]|place[44]|organization[45]	giv[34]|new[41]|new[44]|new[45]	_	_
6-28	623-626	LLP	person[34]|person[41]|organization[45]	giv[34]|new[41]|new[45]	_	_
6-29	627-628	.	_	_	_	_

#Text=Previously she served as Senior Managing Director of Lehman Brothers , Bear Stearns , and the Peter J. Solomon Company . [ 4 ] [ 5 ]
7-1	629-639	Previously	_	_	_	_
7-2	640-643	she	person	giv	_	_
7-3	644-650	served	_	_	_	_
7-4	651-653	as	_	_	_	_
7-5	654-660	Senior	person[48]	new[48]	coref	22-6[132_48]
7-6	661-669	Managing	organization|person[48]	new|new[48]	coref	20-4
7-7	670-678	Director	person[48]	new[48]	_	_
7-8	679-681	of	person[48]	new[48]	_	_
7-9	682-688	Lehman	person[48]|person	new[48]|new	coref	8-11[58_0]
7-10	689-697	Brothers	person[48]|person	new[48]|new	_	_
7-11	698-699	,	person[48]	new[48]	_	_
7-12	700-704	Bear	person[48]|organization[51]	new[48]|new[51]	coref	22-11[133_51]
7-13	705-712	Stearns	person[48]|organization[51]	new[48]|new[51]	_	_
7-14	713-714	,	_	_	_	_
7-15	715-718	and	_	_	_	_
7-16	719-722	the	organization[53]	new[53]	_	_
7-17	723-728	Peter	person[52]|organization[53]	new[52]|new[53]	coref	23-14[148_52]
7-18	729-731	J.	person[52]|organization[53]	new[52]|new[53]	_	_
7-19	732-739	Solomon	person[52]|organization[53]	new[52]|new[53]	_	_
7-20	740-747	Company	organization[53]	new[53]	_	_
7-21	748-749	.	_	_	_	_
7-22	750-751	[	_	_	_	_
7-23	752-753	4	abstract	giv	coref	9-25
7-24	754-755	]	_	_	_	_
7-25	756-757	[	_	_	_	_
7-26	758-759	5	abstract	giv	coref	9-15
7-27	760-761	]	_	_	_	_

#Text=Tanner was the first woman to become a partner at Lehman Brothers . [ 6 ]
8-1	762-768	Tanner	person	giv	coref	8-3[57_0]
8-2	769-772	was	_	_	_	_
8-3	773-776	the	person[57]	giv[57]	ana	9-1[0_57]
8-4	777-782	first	person[57]	giv[57]	_	_
8-5	783-788	woman	person[57]	giv[57]	_	_
8-6	789-791	to	person[57]	giv[57]	_	_
8-7	792-798	become	person[57]	giv[57]	_	_
8-8	799-800	a	person[57]	giv[57]	_	_
8-9	801-808	partner	person[57]	giv[57]	_	_
8-10	809-811	at	person[57]	giv[57]	_	_
8-11	812-818	Lehman	person[57]|person[58]	giv[57]|giv[58]	coref	16-11[99_58]
8-12	819-827	Brothers	person[57]|person[58]	giv[57]|giv[58]	_	_
8-13	828-829	.	_	_	_	_
8-14	830-831	[	_	_	_	_
8-15	832-833	6	abstract	new	coref	14-15
8-16	834-835	]	_	_	_	_

#Text=She is credited with directing over 130 IPOs for life sciences organizations , [ 5 ] and over 500 mergers and acquisitions . [ 4 ]
9-1	836-839	She	person	giv	coref	11-1[73_0]
9-2	840-842	is	_	_	_	_
9-3	843-851	credited	_	_	_	_
9-4	852-856	with	_	_	_	_
9-5	857-866	directing	_	_	_	_
9-6	867-871	over	abstract[61]|abstract[62]	new[61]|new[62]	coref|coref	30-5[207_61]|30-5[208_62]
9-7	872-875	130	abstract[61]|abstract[62]	new[61]|new[62]	_	_
9-8	876-880	IPOs	abstract[61]|abstract[62]	new[61]|new[62]	_	_
9-9	881-884	for	abstract[61]|abstract[62]	new[61]|new[62]	_	_
9-10	885-889	life	abstract[61]|abstract[62]|abstract|abstract[64]|organization[65]	new[61]|new[62]|new|new[64]|new[65]	coref|coref	10-1[71_0]|22-30[140_64]
9-11	890-898	sciences	abstract[61]|abstract[62]|abstract[64]|organization[65]	new[61]|new[62]|new[64]|new[65]	_	_
9-12	899-912	organizations	abstract[61]|abstract[62]|organization[65]	new[61]|new[62]|new[65]	_	_
9-13	913-914	,	abstract[62]	new[62]	_	_
9-14	915-916	[	abstract[62]	new[62]	_	_
9-15	917-918	5	abstract[62]|abstract	new[62]|giv	coref	14-18
9-16	919-920	]	abstract[62]	new[62]	_	_
9-17	921-924	and	abstract[62]	new[62]	_	_
9-18	925-929	over	abstract[62]|event[67]|event[68]	new[62]|new[67]|new[68]	coref|coref	30-12[210_67]|30-12[211_68]
9-19	930-933	500	abstract[62]|event[67]|event[68]	new[62]|new[67]|new[68]	_	_
9-20	934-941	mergers	abstract[62]|event[67]|event[68]	new[62]|new[67]|new[68]	_	_
9-21	942-945	and	abstract[62]|event[68]	new[62]|new[68]	_	_
9-22	946-958	acquisitions	abstract[62]|event[68]|abstract	new[62]|new[68]|new	_	_
9-23	959-960	.	_	_	_	_
9-24	961-962	[	_	_	_	_
9-25	963-964	4	abstract	giv	coref	28-27
9-26	965-966	]	_	_	_	_

#Text=Early life and education
10-1	967-972	Early	abstract[71]	giv[71]	coref	23-30[0_71]
10-2	973-977	life	abstract[71]	giv[71]	_	_
10-3	978-981	and	_	_	_	_
10-4	982-991	education	abstract	new	_	_

#Text=Mary Catherine Tanner was born to Donald N. Tanner and Marilyn S. Tanner .
11-1	992-996	Mary	person[73]	giv[73]	coref	11-7[74_73]
11-2	997-1006	Catherine	person[73]	giv[73]	_	_
11-3	1007-1013	Tanner	person[73]	giv[73]	_	_
11-4	1014-1017	was	_	_	_	_
11-5	1018-1022	born	_	_	_	_
11-6	1023-1025	to	_	_	_	_
11-7	1026-1032	Donald	person[74]|person[75]	giv[74]|giv[75]	coref|coref	11-7[75_74]|11-11[76_75]
11-8	1033-1035	N.	person[74]|person[75]	giv[74]|giv[75]	_	_
11-9	1036-1042	Tanner	person[74]|person[75]	giv[74]|giv[75]	_	_
11-10	1043-1046	and	person[75]	giv[75]	_	_
11-11	1047-1054	Marilyn	person[75]|person[76]	giv[75]|giv[76]	ana	12-1[0_76]
11-12	1055-1057	S.	person[75]|person[76]	giv[75]|giv[76]	_	_
11-13	1058-1064	Tanner	person[75]|person[76]	giv[75]|giv[76]	_	_
11-14	1065-1066	.	_	_	_	_

#Text=Her father was a civil engineer .
12-1	1067-1070	Her	person|person[78]	giv|new[78]	coref|coref	12-4[79_78]|14-1
12-2	1071-1077	father	person[78]	new[78]	_	_
12-3	1078-1081	was	_	_	_	_
12-4	1082-1083	a	person[79]	giv[79]	ana	13-1[0_79]
12-5	1084-1089	civil	person[79]	giv[79]	_	_
12-6	1090-1098	engineer	person[79]	giv[79]	_	_
12-7	1099-1100	.	_	_	_	_

#Text=Her mother was an educator working with learning-disabled children . [ 3 ]
13-1	1101-1104	Her	person|person[81]	giv|new[81]	coref	13-4[82_81]
13-2	1105-1111	mother	person[81]	new[81]	_	_
13-3	1112-1115	was	_	_	_	_
13-4	1116-1118	an	person[82]	giv[82]	_	_
13-5	1119-1127	educator	person[82]	giv[82]	_	_
13-6	1128-1135	working	person[82]	giv[82]	_	_
13-7	1136-1140	with	person[82]	giv[82]	_	_
13-8	1141-1158	learning-disabled	person[82]|person[83]	giv[82]|new[83]	ana	19-11[0_83]
13-9	1159-1167	children	person[82]|person[83]	giv[82]|new[83]	_	_
13-10	1168-1169	.	_	_	_	_
13-11	1170-1171	[	_	_	_	_
13-12	1172-1173	3	abstract	new	coref	19-16
13-13	1174-1175	]	_	_	_	_

#Text=Tanner graduated from Harvard University in 1973 with a B.A. in philosophy , [ 6 ] [ 5 ] magna cum laude . [ 1 ]
14-1	1176-1182	Tanner	person	giv	coref	16-4
14-2	1183-1192	graduated	_	_	_	_
14-3	1193-1197	from	_	_	_	_
14-4	1198-1205	Harvard	organization[86]	new[86]	_	_
14-5	1206-1216	University	organization[86]	new[86]	_	_
14-6	1217-1219	in	_	_	_	_
14-7	1220-1224	1973	time	new	_	_
14-8	1225-1229	with	_	_	_	_
14-9	1230-1231	a	abstract[88]	new[88]	_	_
14-10	1232-1236	B.A.	abstract[88]	new[88]	_	_
14-11	1237-1239	in	abstract[88]	new[88]	_	_
14-12	1240-1250	philosophy	abstract[88]|abstract	new[88]|new	_	_
14-13	1251-1252	,	_	_	_	_
14-14	1253-1254	[	_	_	_	_
14-15	1255-1256	6	abstract	giv	coref	26-20
14-16	1257-1258	]	_	_	_	_
14-17	1259-1260	[	_	_	_	_
14-18	1261-1262	5	abstract	giv	coref	30-9
14-19	1263-1264	]	_	_	_	_
14-20	1265-1270	magna	place|abstract[93]	new|new[93]	_	_
14-21	1271-1274	cum	abstract[93]	new[93]	_	_
14-22	1275-1280	laude	abstract[93]	new[93]	_	_
14-23	1281-1282	.	_	_	_	_
14-24	1283-1284	[	_	_	_	_
14-25	1285-1286	1	abstract	giv	coref	20-11
14-26	1287-1288	]	_	_	_	_

#Text=Career
15-1	1289-1295	Career	abstract	new	_	_

#Text=In 1978 , Tanner was included in a team at Lehman Brothers , to handle Humana 's acquisition of American Medicorp .
16-1	1296-1298	In	_	_	_	_
16-2	1299-1303	1978	time	new	_	_
16-3	1304-1305	,	_	_	_	_
16-4	1306-1312	Tanner	person	giv	coref	18-3
16-5	1313-1316	was	_	_	_	_
16-6	1317-1325	included	_	_	_	_
16-7	1326-1328	in	_	_	_	_
16-8	1329-1330	a	organization[98]	new[98]	coref	17-1[103_98]
16-9	1331-1335	team	organization[98]	new[98]	_	_
16-10	1336-1338	at	organization[98]	new[98]	_	_
16-11	1339-1345	Lehman	organization[98]|person[99]	new[98]|giv[99]	coref	18-9[0_99]
16-12	1346-1354	Brothers	organization[98]|person[99]	new[98]|giv[99]	_	_
16-13	1355-1356	,	_	_	_	_
16-14	1357-1359	to	_	_	_	_
16-15	1360-1366	handle	_	_	_	_
16-16	1367-1373	Humana	organization[100]|event[101]	new[100]|new[101]	_	_
16-17	1374-1376	's	organization[100]|event[101]	new[100]|new[101]	_	_
16-18	1377-1388	acquisition	event[101]	new[101]	_	_
16-19	1389-1391	of	event[101]	new[101]	_	_
16-20	1392-1400	American	event[101]|abstract[102]	new[101]|new[102]	_	_
16-21	1401-1409	Medicorp	event[101]|abstract[102]	new[101]|new[102]	_	_
16-22	1410-1411	.	_	_	_	_

#Text=The team was led by Frederick Frank . [ 7 ]
17-1	1412-1415	The	organization[103]	giv[103]	coref	18-6[109_103]
17-2	1416-1420	team	organization[103]	giv[103]	_	_
17-3	1421-1424	was	_	_	_	_
17-4	1425-1428	led	_	_	_	_
17-5	1429-1431	by	_	_	_	_
17-6	1432-1441	Frederick	person[104]	new[104]	coref	18-1[0_104]
17-7	1442-1447	Frank	person[104]	new[104]	_	_
17-8	1448-1449	.	_	_	_	_
17-9	1450-1451	[	_	_	_	_
17-10	1452-1453	7	abstract	new	_	_
17-11	1454-1455	]	_	_	_	_

#Text=Frank convinced Tanner to join his team at Lehman .
18-1	1456-1461	Frank	person	giv	coref	20-14
18-2	1462-1471	convinced	_	_	_	_
18-3	1472-1478	Tanner	person	giv	ana	18-6
18-4	1479-1481	to	_	_	_	_
18-5	1482-1486	join	_	_	_	_
18-6	1487-1490	his	person|organization[109]	giv|giv[109]	coref	20-1
18-7	1491-1495	team	organization[109]	giv[109]	_	_
18-8	1496-1498	at	_	_	_	_
18-9	1499-1505	Lehman	person	giv	coref	20-7[118_0]
18-10	1506-1507	.	_	_	_	_

#Text=Ten years later , on October 15 , 1988 , they were married . [ 3 ]
19-1	1508-1511	Ten	time[111]	new[111]	coref	21-9[126_111]
19-2	1512-1517	years	time[111]	new[111]	_	_
19-3	1518-1523	later	_	_	_	_
19-4	1524-1525	,	_	_	_	_
19-5	1526-1528	on	_	_	_	_
19-6	1529-1536	October	time[112]	new[112]	coref	25-3[162_112]
19-7	1537-1539	15	time[112]	new[112]	_	_
19-8	1540-1541	,	time[112]	new[112]	_	_
19-9	1542-1546	1988	time[112]|time	new[112]|new	_	_
19-10	1547-1548	,	_	_	_	_
19-11	1549-1553	they	person	giv	_	_
19-12	1554-1558	were	_	_	_	_
19-13	1559-1566	married	_	_	_	_
19-14	1567-1568	.	_	_	_	_
19-15	1569-1570	[	_	_	_	_
19-16	1571-1572	3	abstract	giv	_	_
19-17	1573-1574	]	_	_	_	_

#Text=Tanner became Senior Managing Director of Lehman Brothers , [ 1 ] while Frank became vice chair of Lehman Brothers .
20-1	1575-1581	Tanner	person	giv	coref	21-14
20-2	1582-1588	became	_	_	_	_
20-3	1589-1595	Senior	_	_	_	_
20-4	1596-1604	Managing	organization	giv	coref	22-8
20-5	1605-1613	Director	_	_	_	_
20-6	1614-1616	of	_	_	_	_
20-7	1617-1623	Lehman	person[118]	giv[118]	coref	20-19[122_118]
20-8	1624-1632	Brothers	person[118]	giv[118]	_	_
20-9	1633-1634	,	_	_	_	_
20-10	1635-1636	[	_	_	_	_
20-11	1637-1638	1	abstract	giv	coref	40-25
20-12	1639-1640	]	_	_	_	_
20-13	1641-1646	while	_	_	_	_
20-14	1647-1652	Frank	person	giv	coref	21-1
20-15	1653-1659	became	_	_	_	_
20-16	1660-1664	vice	abstract	new	coref	24-15
20-17	1665-1670	chair	_	_	_	_
20-18	1671-1673	of	_	_	_	_
20-19	1674-1680	Lehman	person[122]	giv[122]	coref	21-7[0_122]
20-20	1681-1689	Brothers	person[122]	giv[122]	_	_
20-21	1690-1691	.	_	_	_	_

#Text=Frank and Tanner worked together at Lehman for over ten years , until Tanner took time off to have a child . [ 2 ]
21-1	1692-1697	Frank	person|person[124]	giv|giv[124]	coref|coref	21-1[124_0]|23-11[147_124]
21-2	1698-1701	and	person[124]	giv[124]	_	_
21-3	1702-1708	Tanner	person[124]	giv[124]	_	_
21-4	1709-1715	worked	_	_	_	_
21-5	1716-1724	together	_	_	_	_
21-6	1725-1727	at	_	_	_	_
21-7	1728-1734	Lehman	person	giv	_	_
21-8	1735-1738	for	_	_	_	_
21-9	1739-1743	over	time[126]	giv[126]	_	_
21-10	1744-1747	ten	time[126]	giv[126]	_	_
21-11	1748-1753	years	time[126]	giv[126]	_	_
21-12	1754-1755	,	_	_	_	_
21-13	1756-1761	until	_	_	_	_
21-14	1762-1768	Tanner	person	giv	coref	22-1
21-15	1769-1773	took	_	_	_	_
21-16	1774-1778	time	_	_	_	_
21-17	1779-1782	off	_	_	_	_
21-18	1783-1785	to	_	_	_	_
21-19	1786-1790	have	_	_	_	_
21-20	1791-1792	a	person[128]	new[128]	_	_
21-21	1793-1798	child	person[128]	new[128]	_	_
21-22	1799-1800	.	_	_	_	_
21-23	1801-1802	[	_	_	_	_
21-24	1803-1804	2	abstract	new	coref	22-18
21-25	1805-1806	]	_	_	_	_

#Text=Tanner returned to work as the Senior Managing Director at Bear Stearns as of 2000 , [ 2 ] and retired from Bear Stearns in 2004 , to found Life Sciences Partners . [ 8 ]
22-1	1807-1813	Tanner	person	giv	coref	23-8[145_0]
22-2	1814-1822	returned	_	_	_	_
22-3	1823-1825	to	_	_	_	_
22-4	1826-1830	work	_	_	_	_
22-5	1831-1833	as	_	_	_	_
22-6	1834-1837	the	person[132]	giv[132]	_	_
22-7	1838-1844	Senior	person[132]	giv[132]	_	_
22-8	1845-1853	Managing	organization|person[132]	giv|giv[132]	coref	24-4
22-9	1854-1862	Director	person[132]	giv[132]	_	_
22-10	1863-1865	at	person[132]	giv[132]	_	_
22-11	1866-1870	Bear	person[132]|organization[133]	giv[132]|giv[133]	coref	33-3[243_133]
22-12	1871-1878	Stearns	person[132]|organization[133]	giv[132]|giv[133]	_	_
22-13	1879-1881	as	_	_	_	_
22-14	1882-1884	of	_	_	_	_
22-15	1885-1889	2000	time	new	_	_
22-16	1890-1891	,	_	_	_	_
22-17	1892-1893	[	_	_	_	_
22-18	1894-1895	2	abstract	giv	_	_
22-19	1896-1897	]	_	_	_	_
22-20	1898-1901	and	_	_	_	_
22-21	1902-1909	retired	_	_	_	_
22-22	1910-1914	from	_	_	_	_
22-23	1915-1919	Bear	organization	new	_	_
22-24	1920-1927	Stearns	person	new	_	_
22-25	1928-1930	in	_	_	_	_
22-26	1931-1935	2004	time	new	_	_
22-27	1936-1937	,	_	_	_	_
22-28	1938-1940	to	_	_	_	_
22-29	1941-1946	found	_	_	_	_
22-30	1947-1951	Life	person|abstract[140]|organization[141]	giv|giv[140]|giv[141]	coref|coref|coref	23-30[154_140]|27-10|27-9[183_141]
22-31	1952-1960	Sciences	abstract[140]|organization[141]	giv[140]|giv[141]	_	_
22-32	1961-1969	Partners	organization[141]	giv[141]	_	_
22-33	1970-1971	.	_	_	_	_
22-34	1972-1973	[	_	_	_	_
22-35	1974-1975	8	abstract	new	_	_
22-36	1976-1977	]	_	_	_	_

#Text=As of March 18 , 2009 , Mary Tanner and Frederick Frank joined Peter J. Solomon , of PJ SOLOMON to form a new practice focusing on pharmaceuticals and life sciences . [ 9 ]
23-1	1978-1980	As	_	_	_	_
23-2	1981-1983	of	_	_	_	_
23-3	1984-1989	March	time[143]	new[143]	coref	40-13[0_143]
23-4	1990-1992	18	time[143]	new[143]	_	_
23-5	1993-1994	,	time[143]	new[143]	_	_
23-6	1995-1999	2009	time[143]|time	new[143]|new	_	_
23-7	2000-2001	,	_	_	_	_
23-8	2002-2006	Mary	person[145]|person[146]	giv[145]|giv[146]	coref|coref	23-8[146_145]|24-1[0_146]
23-9	2007-2013	Tanner	person[145]|person[146]	giv[145]|giv[146]	_	_
23-10	2014-2017	and	person[146]	giv[146]	_	_
23-11	2018-2027	Frederick	person[146]|person[147]	giv[146]|giv[147]	coref	24-12[0_147]
23-12	2028-2033	Frank	person[146]|person[147]	giv[146]|giv[147]	_	_
23-13	2034-2040	joined	_	_	_	_
23-14	2041-2046	Peter	person[148]	giv[148]	coref	24-7[158_148]
23-15	2047-2049	J.	person[148]	giv[148]	_	_
23-16	2050-2057	Solomon	person[148]	giv[148]	_	_
23-17	2058-2059	,	person[148]	giv[148]	_	_
23-18	2060-2062	of	person[148]	giv[148]	_	_
23-19	2063-2065	PJ	person[148]|organization[149]	giv[148]|new[149]	_	_
23-20	2066-2073	SOLOMON	person[148]|organization[149]	giv[148]|new[149]	_	_
23-21	2074-2076	to	_	_	_	_
23-22	2077-2081	form	_	_	_	_
23-23	2082-2083	a	organization[150]	new[150]	_	_
23-24	2084-2087	new	organization[150]	new[150]	_	_
23-25	2088-2096	practice	organization[150]	new[150]	_	_
23-26	2097-2105	focusing	organization[150]	new[150]	_	_
23-27	2106-2108	on	organization[150]	new[150]	_	_
23-28	2109-2124	pharmaceuticals	organization[150]|substance|substance[152]	new[150]|giv|giv[152]	coref	23-28[152_0]
23-29	2125-2128	and	organization[150]|substance[152]	new[150]|giv[152]	_	_
23-30	2129-2133	life	organization[150]|substance[152]|abstract|abstract[154]	new[150]|giv[152]|giv|giv[154]	coref|coref	30-18|30-18[214_154]
23-31	2134-2142	sciences	organization[150]|substance[152]|abstract[154]	new[150]|giv[152]|giv[154]	_	_
23-32	2143-2144	.	_	_	_	_
23-33	2145-2146	[	_	_	_	_
23-34	2147-2148	9	abstract	new	coref	33-22
23-35	2149-2150	]	_	_	_	_

#Text=Tanner became a managing director at Peter J. Solomon , while Frank became a vice chairman . [ 10 ]
24-1	2151-2157	Tanner	person	giv	coref	25-8[164_0]
24-2	2158-2164	became	_	_	_	_
24-3	2165-2166	a	_	_	_	_
24-4	2167-2175	managing	organization	giv	coref	26-5
24-5	2176-2184	director	_	_	_	_
24-6	2185-2187	at	_	_	_	_
24-7	2188-2193	Peter	person[158]	giv[158]	_	_
24-8	2194-2196	J.	person[158]	giv[158]	_	_
24-9	2197-2204	Solomon	person[158]	giv[158]	_	_
24-10	2205-2206	,	_	_	_	_
24-11	2207-2212	while	_	_	_	_
24-12	2213-2218	Frank	person	giv	coref	25-11[166_0]
24-13	2219-2225	became	_	_	_	_
24-14	2226-2227	a	_	_	_	_
24-15	2228-2232	vice	abstract	giv	_	_
24-16	2233-2241	chairman	_	_	_	_
24-17	2242-2243	.	_	_	_	_
24-18	2244-2245	[	_	_	_	_
24-19	2246-2248	10	abstract	new	_	_
24-20	2249-2250	]	_	_	_	_

#Text=As of January 15 , 2013 , Mary Tanner and Frederick Frank joined Burrill & Company . [ 11 ]
25-1	2251-2253	As	_	_	_	_
25-2	2254-2256	of	_	_	_	_
25-3	2257-2264	January	time[162]	giv[162]	coref	38-30[0_162]
25-4	2265-2267	15	time[162]	giv[162]	_	_
25-5	2268-2269	,	time[162]	giv[162]	_	_
25-6	2270-2274	2013	time[162]|time	giv[162]|new	_	_
25-7	2275-2276	,	_	_	_	_
25-8	2277-2281	Mary	person[164]|person[165]	giv[164]|giv[165]	coref|coref	25-8[165_164]|26-1[0_165]
25-9	2282-2288	Tanner	person[164]|person[165]	giv[164]|giv[165]	_	_
25-10	2289-2292	and	person[165]	giv[165]	_	_
25-11	2293-2302	Frederick	person[165]|person[166]	giv[165]|giv[166]	coref	32-5[235_166]
25-12	2303-2308	Frank	person[165]|person[166]	giv[165]|giv[166]	_	_
25-13	2309-2315	joined	_	_	_	_
25-14	2316-2323	Burrill	person	new	coref	26-8
25-15	2324-2325	&	_	_	_	_
25-16	2326-2333	Company	_	_	_	_
25-17	2334-2335	.	_	_	_	_
25-18	2336-2337	[	_	_	_	_
25-19	2338-2340	11	abstract	new	coref	26-17
25-20	2341-2342	]	_	_	_	_

#Text=Tanner became the Senior Managing Director of Burrill Securities and of Burrill & Company . [ 11 ] [ 6 ]
26-1	2343-2349	Tanner	person	giv	coref	27-5
26-2	2350-2356	became	_	_	_	_
26-3	2357-2360	the	person[171]	new[171]	_	_
26-4	2361-2367	Senior	person[171]	new[171]	_	_
26-5	2368-2376	Managing	organization|person[171]	giv|new[171]	_	_
26-6	2377-2385	Director	person[171]	new[171]	_	_
26-7	2386-2388	of	person[171]	new[171]	_	_
26-8	2389-2396	Burrill	person[171]|person|organization[173]	new[171]|giv|new[173]	coref	26-12
26-9	2397-2407	Securities	person[171]|organization[173]	new[171]|new[173]	_	_
26-10	2408-2411	and	_	_	_	_
26-11	2412-2414	of	_	_	_	_
26-12	2415-2422	Burrill	person	giv	_	_
26-13	2423-2424	&	_	_	_	_
26-14	2425-2432	Company	_	_	_	_
26-15	2433-2434	.	_	_	_	_
26-16	2435-2436	[	_	_	_	_
26-17	2437-2439	11	abstract	giv	coref	31-39
26-18	2440-2441	]	_	_	_	_
26-19	2442-2443	[	_	_	_	_
26-20	2444-2445	6	abstract	giv	coref	29-14
26-21	2446-2447	]	_	_	_	_

#Text=As of 2014 , Tanner and Frank founded EVOLUTION Life Science Partners ( ELSP ) . [ 12 ]
27-1	2448-2450	As	_	_	_	_
27-2	2451-2453	of	_	_	_	_
27-3	2454-2458	2014	time	giv	coref	31-2[218_0]
27-4	2459-2460	,	_	_	_	_
27-5	2461-2467	Tanner	person|person[179]	giv|giv[179]	coref|coref	27-5[179_0]|28-1[0_179]
27-6	2468-2471	and	person[179]	giv[179]	_	_
27-7	2472-2477	Frank	person[179]	giv[179]	_	_
27-8	2478-2485	founded	_	_	_	_
27-9	2486-2495	EVOLUTION	organization|organization[182]|organization[183]	giv|giv[182]|giv[183]	coref|coref|coref	28-7|28-8[191_182]|28-7[192_183]
27-10	2496-2500	Life	person|organization[182]|organization[183]	giv|giv[182]|giv[183]	coref	28-8
27-11	2501-2508	Science	organization[182]|organization[183]	giv[182]|giv[183]	_	_
27-12	2509-2517	Partners	organization[183]	giv[183]	_	_
27-13	2518-2519	(	_	_	_	_
27-14	2520-2524	ELSP	abstract	giv	coref	28-12
27-15	2525-2526	)	_	_	_	_
27-16	2527-2528	.	_	_	_	_
27-17	2529-2530	[	_	_	_	_
27-18	2531-2533	12	abstract	new	_	_
27-19	2534-2535	]	_	_	_	_

#Text=Tanner is Senior Managing Director of EVOLUTION Life Science Partners ( ELSP ) , and a co-founder and chair of Life Science Partners LLP . [ 4 ]
28-1	2536-2542	Tanner	person	giv	coref	28-3[187_0]
28-2	2543-2545	is	_	_	_	_
28-3	2546-2552	Senior	person[187]|person[188]	giv[187]|giv[188]	coref|coref	28-3[188_187]|29-1[0_188]
28-4	2553-2561	Managing	person[187]|person[188]	giv[187]|giv[188]	_	_
28-5	2562-2570	Director	person[187]|person[188]	giv[187]|giv[188]	_	_
28-6	2571-2573	of	person[187]|person[188]	giv[187]|giv[188]	_	_
28-7	2574-2583	EVOLUTION	person[187]|person[188]|organization|organization[192]	giv[187]|giv[188]|giv|giv[192]	_	_
28-8	2584-2588	Life	person[187]|person[188]|person|organization[191]|organization[192]	giv[187]|giv[188]|giv|giv[191]|giv[192]	coref|coref	28-21|28-21[197_191]
28-9	2589-2596	Science	person[187]|person[188]|organization[191]|organization[192]	giv[187]|giv[188]|giv[191]|giv[192]	_	_
28-10	2597-2605	Partners	person[187]|person[188]|organization[192]	giv[187]|giv[188]|giv[192]	_	_
28-11	2606-2607	(	person[188]	giv[188]	_	_
28-12	2608-2612	ELSP	person[188]|abstract	giv[188]|giv	_	_
28-13	2613-2614	)	person[188]	giv[188]	_	_
28-14	2615-2616	,	person[188]	giv[188]	_	_
28-15	2617-2620	and	person[188]	giv[188]	_	_
28-16	2621-2622	a	person[188]|person[194]	giv[188]|new[194]	_	_
28-17	2623-2633	co-founder	person[188]|person[194]	giv[188]|new[194]	_	_
28-18	2634-2637	and	person[188]	giv[188]	_	_
28-19	2638-2643	chair	person[188]|person[195]	giv[188]|new[195]	_	_
28-20	2644-2646	of	person[188]|person[195]	giv[188]|new[195]	_	_
28-21	2647-2651	Life	person[188]|person[195]|person|organization[197]|place[198]|organization[199]	giv[188]|new[195]|giv|giv[197]|giv[198]|giv[199]	_	_
28-22	2652-2659	Science	person[188]|person[195]|organization[197]|place[198]|organization[199]	giv[188]|new[195]|giv[197]|giv[198]|giv[199]	_	_
28-23	2660-2668	Partners	person[188]|person[195]|place[198]|organization[199]	giv[188]|new[195]|giv[198]|giv[199]	_	_
28-24	2669-2672	LLP	person[188]|person[195]|organization[199]	giv[188]|new[195]|giv[199]	_	_
28-25	2673-2674	.	_	_	_	_
28-26	2675-2676	[	_	_	_	_
28-27	2677-2678	4	abstract	giv	coref	30-23
28-28	2679-2680	]	_	_	_	_

#Text=Tanner has served on numerous advisory groups and boards of directors . [ 6 ]
29-1	2681-2687	Tanner	person	giv	ana	30-1
29-2	2688-2691	has	_	_	_	_
29-3	2692-2698	served	_	_	_	_
29-4	2699-2701	on	_	_	_	_
29-5	2702-2710	numerous	organization[202]	new[202]	_	_
29-6	2711-2719	advisory	organization[202]	new[202]	_	_
29-7	2720-2726	groups	organization[202]	new[202]	_	_
29-8	2727-2730	and	_	_	_	_
29-9	2731-2737	boards	organization[203]	new[203]	_	_
29-10	2738-2740	of	organization[203]	new[203]	_	_
29-11	2741-2750	directors	organization[203]|person	new[203]|new	_	_
29-12	2751-2752	.	_	_	_	_
29-13	2753-2754	[	_	_	_	_
29-14	2755-2756	6	abstract	giv	_	_
29-15	2757-2758	]	_	_	_	_

#Text=She is credited with over 130 IPOs [ 5 ] and over 500 mergers and acquisitions for life sciences organizations . [ 4 ]
30-1	2759-2762	She	person	giv	ana	31-2
30-2	2763-2765	is	_	_	_	_
30-3	2766-2774	credited	_	_	_	_
30-4	2775-2779	with	_	_	_	_
30-5	2780-2784	over	abstract[207]|abstract[208]	giv[207]|giv[208]	_	_
30-6	2785-2788	130	abstract[207]|abstract[208]	giv[207]|giv[208]	_	_
30-7	2789-2793	IPOs	abstract[207]|abstract[208]	giv[207]|giv[208]	_	_
30-8	2794-2795	[	abstract[208]	giv[208]	_	_
30-9	2796-2797	5	abstract[208]|abstract	giv[208]|giv	coref	31-36
30-10	2798-2799	]	abstract[208]	giv[208]	_	_
30-11	2800-2803	and	abstract[208]	giv[208]	_	_
30-12	2804-2808	over	abstract[208]|event[210]|event[211]	giv[208]|giv[210]|giv[211]	_	_
30-13	2809-2812	500	abstract[208]|event[210]|event[211]	giv[208]|giv[210]|giv[211]	_	_
30-14	2813-2820	mergers	abstract[208]|event[210]|event[211]	giv[208]|giv[210]|giv[211]	_	_
30-15	2821-2824	and	abstract[208]|event[211]	giv[208]|giv[211]	_	_
30-16	2825-2837	acquisitions	abstract[208]|event[211]|abstract[212]	giv[208]|giv[211]|new[212]	_	_
30-17	2838-2841	for	abstract[208]|event[211]|abstract[212]	giv[208]|giv[211]|new[212]	_	_
30-18	2842-2846	life	abstract[208]|event[211]|abstract[212]|abstract|abstract[214]|organization[215]	giv[208]|giv[211]|new[212]|giv|giv[214]|new[215]	_	_
30-19	2847-2855	sciences	abstract[208]|event[211]|abstract[212]|abstract[214]|organization[215]	giv[208]|giv[211]|new[212]|giv[214]|new[215]	_	_
30-20	2856-2869	organizations	abstract[208]|event[211]|abstract[212]|organization[215]	giv[208]|giv[211]|new[212]|new[215]	_	_
30-21	2870-2871	.	_	_	_	_
30-22	2872-2873	[	_	_	_	_
30-23	2874-2875	4	abstract	giv	ana	31-11
30-24	2876-2877	]	_	_	_	_

#Text=During her time at Lehmann , Tanner represented Rhône-Poulenc when it acquired Rorer for $ 1.8 billion in 1990 , and in 1995 represented Rhône-Poulenc Rorer when it acquired Fisons for £1.8 billion . [ 5 ] [ 11 ]
31-1	2878-2884	During	_	_	_	_
31-2	2885-2888	her	person|time[218]	giv|giv[218]	coref	31-7
31-3	2889-2893	time	time[218]	giv[218]	_	_
31-4	2894-2896	at	time[218]	giv[218]	_	_
31-5	2897-2904	Lehmann	time[218]|person	giv[218]|new	_	_
31-6	2905-2906	,	_	_	_	_
31-7	2907-2913	Tanner	person	giv	coref	32-3
31-8	2914-2925	represented	_	_	_	_
31-9	2926-2939	Rhône-Poulenc	person	new	_	_
31-10	2940-2944	when	_	_	_	_
31-11	2945-2947	it	abstract	giv	ana	31-28
31-12	2948-2956	acquired	_	_	_	_
31-13	2957-2962	Rorer	person	new	coref	31-25[227_0]
31-14	2963-2966	for	_	_	_	_
31-15	2967-2968	$	abstract[224]	new[224]	_	_
31-16	2969-2972	1.8	abstract[224]	new[224]	_	_
31-17	2973-2980	billion	abstract[224]	new[224]	_	_
31-18	2981-2983	in	_	_	_	_
31-19	2984-2988	1990	time	new	_	_
31-20	2989-2990	,	_	_	_	_
31-21	2991-2994	and	_	_	_	_
31-22	2995-2997	in	_	_	_	_
31-23	2998-3002	1995	time	new	coref	32-25
31-24	3003-3014	represented	_	_	_	_
31-25	3015-3028	Rhône-Poulenc	person[227]	giv[227]	_	_
31-26	3029-3034	Rorer	person[227]	giv[227]	_	_
31-27	3035-3039	when	_	_	_	_
31-28	3040-3042	it	abstract	giv	ana	32-12
31-29	3043-3051	acquired	_	_	_	_
31-30	3052-3058	Fisons	person	new	_	_
31-31	3059-3062	for	_	_	_	_
31-32	3063-3067	£1.8	abstract[230]	new[230]	_	_
31-33	3068-3075	billion	abstract[230]	new[230]	_	_
31-34	3076-3077	.	_	_	_	_
31-35	3078-3079	[	_	_	_	_
31-36	3080-3081	5	abstract	giv	coref	34-15
31-37	3082-3083	]	_	_	_	_
31-38	3084-3085	[	_	_	_	_
31-39	3086-3088	11	abstract	giv	coref	32-28
31-40	3089-3090	]	_	_	_	_

#Text=Together , Tanner and Frederick Frank represented Marion Merrell Dow in its merger with Hoechst AG , forming Hoechst Marion Roussel , Inc. in 1995 . [ 11 ]
32-1	3091-3099	Together	_	_	_	_
32-2	3100-3101	,	_	_	_	_
32-3	3102-3108	Tanner	person|person[234]	giv|giv[234]	coref|coref	32-3[234_0]|33-6[0_234]
32-4	3109-3112	and	person[234]	giv[234]	_	_
32-5	3113-3122	Frederick	person[234]|person[235]	giv[234]|giv[235]	coref	36-10[0_235]
32-6	3123-3128	Frank	person[234]|person[235]	giv[234]|giv[235]	_	_
32-7	3129-3140	represented	_	_	_	_
32-8	3141-3147	Marion	person[236]	new[236]	_	_
32-9	3148-3155	Merrell	person[236]	new[236]	_	_
32-10	3156-3159	Dow	person[236]	new[236]	_	_
32-11	3160-3162	in	_	_	_	_
32-12	3163-3166	its	abstract|event[238]	giv|new[238]	_	_
32-13	3167-3173	merger	event[238]	new[238]	_	_
32-14	3174-3178	with	event[238]	new[238]	_	_
32-15	3179-3186	Hoechst	event[238]|organization[239]	new[238]|new[239]	_	_
32-16	3187-3189	AG	event[238]|organization[239]	new[238]|new[239]	_	_
32-17	3190-3191	,	_	_	_	_
32-18	3192-3199	forming	_	_	_	_
32-19	3200-3207	Hoechst	organization[240]	new[240]	_	_
32-20	3208-3214	Marion	organization[240]	new[240]	_	_
32-21	3215-3222	Roussel	organization[240]	new[240]	_	_
32-22	3223-3224	,	_	_	_	_
32-23	3225-3229	Inc.	_	_	_	_
32-24	3230-3232	in	_	_	_	_
32-25	3233-3237	1995	time	giv	_	_
32-26	3238-3239	.	_	_	_	_
32-27	3240-3241	[	_	_	_	_
32-28	3242-3244	11	abstract	giv	coref	34-18
32-29	3245-3246	]	_	_	_	_

#Text=While at Bear Stearns , Tanner represented Pfizer when it acquired Pharmacia for $ 60 billion ( 2002-2003 ) . [ 9 ] [ 13 ]
33-1	3247-3252	While	_	_	_	_
33-2	3253-3255	at	_	_	_	_
33-3	3256-3260	Bear	organization[243]	giv[243]	_	_
33-4	3261-3268	Stearns	organization[243]	giv[243]	_	_
33-5	3269-3270	,	_	_	_	_
33-6	3271-3277	Tanner	person	giv	ana	34-1
33-7	3278-3289	represented	_	_	_	_
33-8	3290-3296	Pfizer	organization	new	ana	33-10
33-9	3297-3301	when	_	_	_	_
33-10	3302-3304	it	organization	giv	_	_
33-11	3305-3313	acquired	_	_	_	_
33-12	3314-3323	Pharmacia	organization	new	_	_
33-13	3324-3327	for	_	_	_	_
33-14	3328-3329	$	_	_	_	_
33-15	3330-3332	60	_	_	_	_
33-16	3333-3340	billion	_	_	_	_
33-17	3341-3342	(	_	_	_	_
33-18	3343-3352	2002-2003	time	new	_	_
33-19	3353-3354	)	_	_	_	_
33-20	3355-3356	.	_	_	_	_
33-21	3357-3358	[	_	_	_	_
33-22	3359-3360	9	abstract	giv	_	_
33-23	3361-3362	]	_	_	_	_
33-24	3363-3364	[	_	_	_	_
33-25	3365-3367	13	abstract	new	_	_
33-26	3368-3369	]	_	_	_	_

#Text=She also represented Amgen when it acquired Immunex for $ 16 billion . [ 5 ] [ 11 ]
34-1	3370-3373	She	person	giv	coref	36-9
34-2	3374-3378	also	_	_	_	_
34-3	3379-3390	represented	_	_	_	_
34-4	3391-3396	Amgen	organization	new	ana	34-6
34-5	3397-3401	when	_	_	_	_
34-6	3402-3404	it	organization	giv	_	_
34-7	3405-3413	acquired	_	_	_	_
34-8	3414-3421	Immunex	organization	new	_	_
34-9	3422-3425	for	_	_	_	_
34-10	3426-3427	$	_	_	_	_
34-11	3428-3430	16	abstract[255]	new[255]	_	_
34-12	3431-3438	billion	abstract[255]	new[255]	_	_
34-13	3439-3440	.	_	_	_	_
34-14	3441-3442	[	_	_	_	_
34-15	3443-3444	5	abstract	giv	coref	37-31
34-16	3445-3446	]	_	_	_	_
34-17	3447-3448	[	_	_	_	_
34-18	3449-3451	11	abstract	giv	_	_
34-19	3452-3453	]	_	_	_	_

#Text=Philanthropy
35-1	3454-3466	Philanthropy	person	new	_	_

#Text=As of October , 1997 , the non-profit Tanner Frank Foundation of New York City was granted charitable status . [ 14 ]
36-1	3467-3469	As	_	_	_	_
36-2	3470-3472	of	_	_	_	_
36-3	3473-3480	October	time[259]	new[259]	appos	36-5[0_259]
36-4	3481-3482	,	time[259]	new[259]	_	_
36-5	3483-3487	1997	time[259]|time	new[259]|giv	_	_
36-6	3488-3489	,	_	_	_	_
36-7	3490-3493	the	organization[263]	new[263]	_	_
36-8	3494-3504	non-profit	organization[263]	new[263]	_	_
36-9	3505-3511	Tanner	person|organization[263]	giv|new[263]	coref	37-1
36-10	3512-3517	Frank	person|organization[263]	giv|new[263]	coref	38-37[293_0]
36-11	3518-3528	Foundation	organization[263]	new[263]	_	_
36-12	3529-3531	of	organization[263]	new[263]	_	_
36-13	3532-3535	New	organization[263]|place[264]	new[263]|new[264]	_	_
36-14	3536-3540	York	organization[263]|place[264]	new[263]|new[264]	_	_
36-15	3541-3545	City	organization[263]|place[264]	new[263]|new[264]	_	_
36-16	3546-3549	was	_	_	_	_
36-17	3550-3557	granted	_	_	_	_
36-18	3558-3568	charitable	abstract[265]	new[265]	_	_
36-19	3569-3575	status	abstract[265]	new[265]	_	_
36-20	3576-3577	.	_	_	_	_
36-21	3578-3579	[	_	_	_	_
36-22	3580-3582	14	abstract	new	coref	38-12
36-23	3583-3584	]	_	_	_	_

#Text=Tanner has served on the Dean 's Council for the Yale School of Medicine and on the advisory board for the Yale School of Management ( SOM ) . [ 5 ]
37-1	3585-3591	Tanner	person	giv	coref	38-1
37-2	3592-3595	has	_	_	_	_
37-3	3596-3602	served	_	_	_	_
37-4	3603-3605	on	_	_	_	_
37-5	3606-3609	the	organization[269]	new[269]	_	_
37-6	3610-3614	Dean	person[268]|organization[269]	new[268]|new[269]	_	_
37-7	3615-3617	's	person[268]|organization[269]	new[268]|new[269]	_	_
37-8	3618-3625	Council	organization[269]	new[269]	_	_
37-9	3626-3629	for	organization[269]	new[269]	_	_
37-10	3630-3633	the	organization[269]|organization[271]	new[269]|new[271]	coref	38-23[289_271]
37-11	3634-3638	Yale	organization[269]|place|organization[271]	new[269]|new|new[271]	coref	37-22
37-12	3639-3645	School	organization[269]|organization[271]	new[269]|new[271]	_	_
37-13	3646-3648	of	organization[269]|organization[271]	new[269]|new[271]	_	_
37-14	3649-3657	Medicine	organization[269]|organization[271]|abstract	new[269]|new[271]|new	coref	38-27
37-15	3658-3661	and	_	_	_	_
37-16	3662-3664	on	_	_	_	_
37-17	3665-3668	the	organization[273]	new[273]	_	_
37-18	3669-3677	advisory	organization[273]	new[273]	_	_
37-19	3678-3683	board	organization[273]	new[273]	_	_
37-20	3684-3687	for	organization[273]	new[273]	_	_
37-21	3688-3691	the	organization[273]|organization[275]	new[273]|new[275]	_	_
37-22	3692-3696	Yale	organization[273]|place|organization[275]	new[273]|giv|new[275]	coref	38-9
37-23	3697-3703	School	organization[273]|organization[275]	new[273]|new[275]	_	_
37-24	3704-3706	of	organization[273]|organization[275]	new[273]|new[275]	_	_
37-25	3707-3717	Management	organization[273]|organization[275]|abstract	new[273]|new[275]|new	_	_
37-26	3718-3719	(	_	_	_	_
37-27	3720-3723	SOM	abstract	new	_	_
37-28	3724-3725	)	_	_	_	_
37-29	3726-3727	.	_	_	_	_
37-30	3728-3729	[	_	_	_	_
37-31	3730-3731	5	abstract	giv	_	_
37-32	3732-3733	]	_	_	_	_

#Text=Tanner and Frank have made multiple gifts to Yale , [ 14 ] including early career support of researchers in autism at the Yale School of Medicine , [ 15 ] and the creation of the Frank and Tanner Professor of Management at the Yale School of Management , to which Olav Sorenson was appointed on April 9 , 2012 . [ 16 ]
38-1	3734-3740	Tanner	person|person[280]	giv|giv[280]	coref	38-1[280_0]
38-2	3741-3744	and	person[280]	giv[280]	_	_
38-3	3745-3750	Frank	person[280]	giv[280]	_	_
38-4	3751-3755	have	_	_	_	_
38-5	3756-3760	made	_	_	_	_
38-6	3761-3769	multiple	abstract[281]	new[281]	_	_
38-7	3770-3775	gifts	abstract[281]	new[281]	_	_
38-8	3776-3778	to	abstract[281]	new[281]	_	_
38-9	3779-3783	Yale	abstract[281]|place	new[281]|giv	coref	38-24
38-10	3784-3785	,	abstract[281]	new[281]	_	_
38-11	3786-3787	[	abstract[281]	new[281]	_	_
38-12	3788-3790	14	abstract[281]|abstract	new[281]|giv	_	_
38-13	3791-3792	]	abstract[281]	new[281]	_	_
38-14	3793-3802	including	abstract[281]	new[281]	_	_
38-15	3803-3808	early	abstract[281]|abstract[285]	new[281]|new[285]	_	_
38-16	3809-3815	career	abstract[281]|person|abstract[285]	new[281]|new|new[285]	_	_
38-17	3816-3823	support	abstract[281]|abstract[285]	new[281]|new[285]	_	_
38-18	3824-3826	of	abstract[281]|abstract[285]	new[281]|new[285]	_	_
38-19	3827-3838	researchers	abstract[281]|abstract[285]|person[286]	new[281]|new[285]|new[286]	_	_
38-20	3839-3841	in	abstract[281]|abstract[285]|person[286]	new[281]|new[285]|new[286]	_	_
38-21	3842-3848	autism	abstract[281]|abstract[285]|person[286]|abstract	new[281]|new[285]|new[286]|new	_	_
38-22	3849-3851	at	abstract[281]|abstract[285]|person[286]	new[281]|new[285]|new[286]	_	_
38-23	3852-3855	the	abstract[281]|abstract[285]|person[286]|organization[289]	new[281]|new[285]|new[286]|giv[289]	_	_
38-24	3856-3860	Yale	abstract[281]|abstract[285]|person[286]|place|organization[289]	new[281]|new[285]|new[286]|giv|giv[289]	_	_
38-25	3861-3867	School	abstract[281]|abstract[285]|person[286]|organization[289]	new[281]|new[285]|new[286]|giv[289]	_	_
38-26	3868-3870	of	abstract[281]|abstract[285]|person[286]|organization[289]	new[281]|new[285]|new[286]|giv[289]	_	_
38-27	3871-3879	Medicine	abstract[281]|abstract[285]|person[286]|organization[289]|abstract	new[281]|new[285]|new[286]|giv[289]|giv	_	_
38-28	3880-3881	,	_	_	_	_
38-29	3882-3883	[	_	_	_	_
38-30	3884-3886	15	time	giv	_	_
38-31	3887-3888	]	_	_	_	_
38-32	3889-3892	and	_	_	_	_
38-33	3893-3896	the	event[292]	new[292]	_	_
38-34	3897-3905	creation	event[292]	new[292]	_	_
38-35	3906-3908	of	event[292]	new[292]	_	_
38-36	3909-3912	the	event[292]	new[292]	_	_
38-37	3913-3918	Frank	event[292]|person[293]	new[292]|giv[293]	_	_
38-38	3919-3922	and	event[292]|person[293]	new[292]|giv[293]	_	_
38-39	3923-3929	Tanner	event[292]|person[293]	new[292]|giv[293]	_	_
38-40	3930-3939	Professor	event[292]	new[292]	_	_
38-41	3940-3942	of	event[292]	new[292]	_	_
38-42	3943-3953	Management	event[292]	new[292]	_	_
38-43	3954-3956	at	event[292]	new[292]	_	_
38-44	3957-3960	the	event[292]	new[292]	_	_
38-45	3961-3965	Yale	event[292]	new[292]	_	_
38-46	3966-3972	School	event[292]	new[292]	_	_
38-47	3973-3975	of	event[292]	new[292]	_	_
38-48	3976-3986	Management	event[292]	new[292]	_	_
38-49	3987-3988	,	event[292]	new[292]	_	_
38-50	3989-3991	to	event[292]	new[292]	_	_
38-51	3992-3997	which	event[292]	new[292]	_	_
38-52	3998-4002	Olav	event[292]	new[292]	_	_
38-53	4003-4011	Sorenson	event[292]	new[292]	_	_
38-54	4012-4015	was	event[292]	new[292]	_	_
38-55	4016-4025	appointed	event[292]	new[292]	_	_
38-56	4026-4028	on	event[292]	new[292]	_	_
38-57	4029-4034	April	event[292]	new[292]	_	_
38-58	4035-4036	9	event[292]	new[292]	_	_
38-59	4037-4038	,	event[292]	new[292]	_	_
38-60	4039-4043	2012	event[292]	new[292]	_	_
38-61	4044-4045	.	_	_	_	_
38-62	4046-4047	[	_	_	_	_
38-63	4048-4050	16	abstract	new	_	_
38-64	4051-4052	]	_	_	_	_

#Text=Awards and honors
39-1	4053-4059	Awards	abstract	new	_	_
39-2	4060-4063	and	_	_	_	_
39-3	4064-4070	honors	abstract	new	_	_

#Text=2012 , Oracle award , Springboard Enterprises , [ 17 ] [ 18 ] for professional accomplishment and mentoring of women entrepreneurs . [ 1 ]
40-1	4071-4075	2012	time|abstract[299]	new|new[299]	_	_
40-2	4076-4077	,	abstract[299]	new[299]	_	_
40-3	4078-4084	Oracle	person|abstract[299]	new|new[299]	_	_
40-4	4085-4090	award	abstract[299]	new[299]	_	_
40-5	4091-4092	,	_	_	_	_
40-6	4093-4104	Springboard	object|organization[301]	new|new[301]	_	_
40-7	4105-4116	Enterprises	organization[301]	new[301]	_	_
40-8	4117-4118	,	_	_	_	_
40-9	4119-4120	[	_	_	_	_
40-10	4121-4123	17	abstract	new	_	_
40-11	4124-4125	]	_	_	_	_
40-12	4126-4127	[	_	_	_	_
40-13	4128-4130	18	time	giv	_	_
40-14	4131-4132	]	_	_	_	_
40-15	4133-4136	for	_	_	_	_
40-16	4137-4149	professional	abstract[304]	new[304]	_	_
40-17	4150-4164	accomplishment	abstract[304]	new[304]	_	_
40-18	4165-4168	and	_	_	_	_
40-19	4169-4178	mentoring	_	_	_	_
40-20	4179-4181	of	_	_	_	_
40-21	4182-4187	women	person[305]	new[305]	_	_
40-22	4188-4201	entrepreneurs	person[305]	new[305]	_	_
40-23	4202-4203	.	_	_	_	_
40-24	4204-4205	[	_	_	_	_
40-25	4206-4207	1	abstract	giv	_	_
40-26	4208-4209	]	_	_	_	_
